| As of: October 22, 2004 |
| |
|
|
|
|
|
|
|
|
|
|
| North Division |
Win |
Loss |
Tie |
G/S |
Adj. G/S |
G/A |
Adj. G/A |
Pts. |
FF |
Ratio |
| CDS |
6 |
0 |
2 |
34 |
34 |
14 |
14 |
14 |
0 |
2.500 |
| Deloitte & Touche |
4 |
2 |
2 |
18 |
18 |
10 |
10 |
10 |
0 |
1.000 |
| Picatinny Arsenal |
3 |
1 |
3 |
27 |
27 |
20 |
20 |
9 |
0 |
1.000 |
| Novartis |
3 |
2 |
3 |
15 |
15 |
16 |
16 |
9 |
0 |
-0.125 |
| ADP |
3 |
3 |
1 |
25 |
25 |
15 |
15 |
7 |
1 |
1.667 |
| Siemens/TDI |
1 |
5 |
1 |
15 |
15 |
28 |
28 |
3 |
0 |
-1.857 |
| Kraft/PNY |
0 |
7 |
0 |
5 |
5 |
35 |
35 |
0 |
1 |
-5.000 |
| |
20 |
20 |
12 |
|
|
|
|
|
|
|
| South Division |
Win |
Loss |
Tie |
G/S |
Adj. G/S |
G/A |
Adj. G/A |
Pts. |
FF |
Ratio |
| Tiffany |
5 |
1 |
1 |
23 |
23 |
15 |
15 |
11 |
1 |
1.333 |
| Honeywell/Bayer |
4 |
2 |
1 |
14 |
14 |
12 |
12 |
9 |
0 |
0.286 |
| Aircast |
3 |
3 |
1 |
13 |
13 |
19 |
19 |
7 |
2 |
-1.200 |
| Solgar |
3 |
4 |
0 |
16 |
15 |
8 |
8 |
6 |
3 |
1.750 |
| Bear Stearns |
2 |
3 |
1 |
22 |
22 |
15 |
15 |
5 |
0 |
1.167 |
| B.Moore/Champ.Mortg. |
0 |
6 |
0 |
10 |
10 |
29 |
28 |
0 |
0 |
-3.000 |
| |
17 |
19 |
4 |
|
|
|
|
|
|
|
| Mixed Division |
Win |
Loss |
Tie |
G/S |
Adj. G/S |
G/A |
Adj. G/A |
Pts. |
FF |
Ratio |
| Pfizer |
5 |
0 |
2 |
18 |
18 |
12 |
12 |
12 |
0 |
0.857 |
| Wyeth/Ayco |
4 |
1 |
2 |
16 |
16 |
5 |
5 |
10 |
0 |
1.571 |
| Dendrite International |
3 |
3 |
1 |
19 |
18 |
13 |
13 |
7 |
0 |
0.714 |
| AC Nielsen Bases |
3 |
3 |
0 |
9 |
9 |
14 |
14 |
6 |
0 |
-0.833 |
| PricewaterhouseCoopers |
1 |
5 |
1 |
9 |
9 |
15 |
15 |
3 |
0 |
-0.857 |
| Cendant |
1 |
5 |
0 |
7 |
7 |
19 |
19 |
2 |
0 |
-2.000 |
| |
17 |
17 |
6 |
|
|
|
|
|
|
|
Last Updated on 12/9/2004
By Fred P. Fusco